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Multi-parameter evidence synthesis (MPES) is receiving grow-
ing attention from the epidemiological community as a coherent and
flexible analytical framework to accommodate a disparate body of
evidence available to inform disease incidence and prevalence esti-
mation. MPES is the statistical methodology adopted by the Health
Protection Agency in the UK for its annual national assessment of
the HIV epidemic, and is acknowledged by the World Health Orga-
nization and UNAIDS as a valuable technique for the estimation of
adult HIV prevalence from surveillance data. This paper describes
the results of utilizing a Bayesian MPES approach to model HIV
prevalence in the Netherlands at the end of 2007, using an array of
field data from different study designs on various population risk sub-
groups and with a varying degree of regional coverage. Auxiliary data
and expert opinion were additionally incorporated to resolve issues
arising from biased, insufficient or inconsistent evidence. This case
study offers a demonstration of the ability of MPES to naturally in-
tegrate and critically reconcile disparate and heterogeneous sources of
evidence, while producing reliable estimates of HIV prevalence used
to support public health decision-making.
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1. Introduction. Refining and advancing the current understanding of
the dynamics of the HIV epidemic attracts a continued interest from the epi-
demiological and medical community. Both national and international public
health institutes recognize the importance of improving current methods to
monitor HIV prevalence, as this constitutes a key input to inform public
health-care policies and resource allocation.
A number of approaches have been proposed in the statistical literature,
starting from the back-calculation method [Brookmeyer and Gail (1988)],
initially devised to obtain an estimate of HIV prevalence. The most popular
estimation methods (so-called “direct”) typically rely on evidence specif-
ically around HIV prevalence [Giesecke et al. (1994); Petruckevitch et al.
(1997); Houweling et al. (1998); Karon, Khare and Rosenberg (1998); Ramo´n
et al. (2002); McGarrigle et al. (2006)]. In broad terms, direct methods as-
sume a target population of size N =
∑
gNg to be divided into mutually
exclusive subgroups g = 1, . . . ,G of corresponding size Ng. Each subgroup is
characterized by a given degree of risk behavior and consists of Ng(1− pig)
uninfected and Ngpig infected individuals, where pig denotes the unknown
subgroup-specific HIV prevalence. Prevalent cases Ngpig can in turn be
split into Ngpigδg diagnosed and Ngpig(1 − δg) undiagnosed individuals, as
determined by the (unknown) proportion δg of HIV positive cases diag-
nosed within each subgroup. Provided enough cross-sectional surveillance- or
survey-based information is available to estimate subgroup sizes and param-
eters, the number of subgroup-specific diagnosed and undiagnosed prevalent
cases can be inferred by multiplying corresponding estimates of Ng and pig
with δg and 1− δg, respectively. These in turn can be summed across sub-
groups to obtain a point estimate of the total number of HIV infections in
the population.
While at a first glance appealing, direct methods suffer from both con-
ceptual and practical complications. Data may: (i) be insufficient to inform
directly relevant parameters, like prevalence in hard-to-reach subgroups; (ii)
relate to individuals matching multiple risk profiles; and/or (iii) be affected
by selection and reporting biases. Without the inclusion of supplementary
evidence, these problems are normally tackled via unverifiable assumptions,
ad-hoc adjustments and/or removal of selected data [Goubar et al. (2008)].
Moreover, the common practice of using only as many items of (highest
quality) evidence as the number of parameters of interest is hardly justi-
fied under a decision-making perspective. Decisions around research priori-
tization and service provision are more rationally and robustly taken when
driven by a comprehensive, rather than selective, use of available informa-
tion [Claxton, Sculpher and Drummond (2002)], provided the varying degree
of accuracy of the components of the evidence base is correctly recognized
and taken into account in the analysis.
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Conversely, multi-parameter evidence synthesis (henceforth MPES) offers
a coherent analytical framework designed to make rational and exhaustive
use of the whole body of information available [Ades and Sutton (2006)],
thus circumventing the above shortcomings. A disparate pool of evidence is
naturally accommodated within a MPES model structure through its formal
specification of the relationships between data and parameters, which dic-
tate how (direct) evidence on the parameters of interest can be supplemented
by (indirect) information available on arbitrarily complex functions of those
parameters. A MPES approach thus presents a number of advantages over
direct methods: first, since it incorporates more data, a MPES model is
expected to produce more accurate parameter estimates. Consequently, the
inferences it produces correctly reflect the uncertainty surrounding the whole
evidence base. Moreover, where there are more data points than estimands,
MPES flags any inconsistency potentially affecting a collection of heteroge-
neous items of data. These conflicts are important to detect, as they may
highlight biases in, or misinterpretations of, the data, which can be then
addressed.
As an analytical perspective, MPES has in recent years rapidly gained
a foot in medical statistics, health technology assessment and epidemiologi-
cal modeling of infectious diseases like HIV and hepatitis C [Welton and Ades
(2005); Goubar et al. (2008); Presanis et al. (2008); Sweeting et al. (2008);
De Angelis et al. (2009)]. Since 2005 the UK Health Protection Agency em-
ploys a MPES approach to estimate diagnosed and undiagnosed HIV preva-
lences in the UK using data from routine surveillance and ad-hoc surveys
[HIV & STI Department (2005, 2006, 2007, 2008, 2009)]. These evidence
synthesis exercises have typically been carried out from a Bayesian per-
spective, due to its computational convenience, coherent decision-theoretic
foundation and automatic synthesis between empirical and prior/subjective
information.
This paper describes the development of a Bayesian MPES model to es-
timate HIV prevalence in different population subgroups and areas across
the Netherlands, through reliance on its national surveillance network and
an array of regional registries and surveys. The proposed model produces
estimates of prevalence, proportions diagnosed and sizes for a number of pre-
defined subgroup profiles at risk of HIV infection within the target popula-
tion of 15- to 70-year old individuals living in the Netherlands in 2007. The
paper is organized as follows: Section 2 formally defines the MPES approach
adopted. Section 3 describes the body of evidence compiled by the National
Institute for Public Health and the Environment in the Netherlands to en-
able estimation. Section 4 details the MPES model building process, and
results are illustrated in Section 5. Model criticism and concluding remarks
are outlined in Section 6.
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2. The synthesis of evidence. The practice of synthesising evidence from
multiple sources, through the combination of direct and/or indirect infor-
mation from differently designed studies, dates well before dedicated work
emerged under an explicit MPES header. Besides the vast body of litera-
ture on meta-analytis [see Sutton et al. (2000)], of which MPES represents
an extension, a methodological stepping stone in the subject of collating
direct and indirect evidence is widely recognized to be the Confidence Pro-
file Method [Eddy and Hasselblad (1992)]. Instances of complex synthesis
include, but are not limited to, indirect and mixed treatment comparisons
[e.g., Dominici et al. (1999); Song et al. (2003); Lu and Ades (2004); Cald-
well, Ades and Higgins (2005)], cross-design synthesis [Drioycour, Silberman
and Chelimsky (1993); Benson and Hartz (2000)], hierarchical models [exten-
sively reviewed in, e.g., Sutton et al. (2000); Ades and Cliffe (2002); White-
head (2002); Gelman and Hill (2007)], Bayesian melding [Poole and Raftery
(2000); Fuentes and Raftery (2005); Alkema, Raftery and Clark (2007)], bias
adjustment [Spiegelhalter and Best (2003); Wolpert and Mengersen (2004);
Turner et al. (2009)] and multiple/surrogate endpoint synthesis [Berkey et al.
(1998); Nam, Mengersen and Garthwaite (2003); Burzykowski, Molenberghs
and Buyse (2004)]. These examples attempt to integrate separate sources of
evidence to draw inferences that are not only more efficient than those in-
stead obtained from a selective “best data” approach, but also consistent
with all available information.
Formally, a MPES setup follows closely the characterization of the Con-
fidence Profile Method: assume interest lies in learning about I basic pa-
rameters ϑ = (ϑ1, . . . , ϑI), and that for estimation purposes n data points
(i.e., sufficient statistics) y= (y1, . . . , yn) have been separately collected. Any
data point may inform either a basic parameter ϑi or some functional pa-
rameter ψj = ψj(ϑ), j = 1, . . . , J , which can be expressed as a function of
known form of the basic parameters. Data unbiasedly reporting on basic
parameters are normally referred to as “direct” evidence; samples informing
functional parameters are also included in the evidence base, in that they
provide “indirect” evidence about their defining basic parameters. Indicat-
ing with Lr(ϑ;yr) the likelihood contribution from yr to (elements of) the
basic parameter vector ϑ, from the independence of elements in y the full
likelihood model
L(ϑ;y) =
n∏
r=1
Lr(ϑ;yr)(1)
follows.
Within a classical framework, specification of (1) is sufficient to obtain,
typically via maximum likelihood, estimates ϑˆ of the basic parameters and
therefore of the J functional parameters ψˆj = ψj(ϑˆ). Additionally, under
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a Bayesian perspective, prior (imperfect or even scarce) knowledge around
the basic parameters, as expressed through some joint prior distribution p(ϑ),
may be updated in the light of the observed data into a posterior distribu-
tion p(ϑ|y) summarizing all information around ϑ (and thus ψ): that is,
p(ϑ|y)∝ p(ϑ)L(ϑ;y).
As in recent MPES modeling work, a Bayesian approach is here proposed
since its prior-to-posterior updating mechanism naturally corresponds to the
spirit, typical of MPES, of synthesizing multiple items of evidence. Further-
more, the resulting posterior distribution fully reflects both the sampling
variability affecting such evidence and the parameter uncertainty surround-
ing the model.
3. The HIV surveillance network in the Netherlands. In line with Goubar
et al. (2008) and Presanis et al. (2008), and compatibly with the socio-
demographic coverage and resolution of available data, the population living
in the Netherlands at the end of 2007 was classified by mutually exclusive
subgroups and areas of residence. Subgroups are defined as follows:
(1) men who have sex with men (MSM), who have (MSMSTI) or have not
(MSMSTI) attended a sexually-transmitted infections (STI) clinic in 2007;
(2) intravenous drug users (IDU);
(3) female sex workers (FSW);
(4) heterosexuals attending an STI clinic (STI), further divided into Sub-
Saharan Africans (SSASTI), Caribbeans (CRBSTI) and nonmigrants (WSTSTI);
(5) heterosexuals not attending an STI clinic (thus supposedly at low risk
of infection), further divided into Sub-Saharan Africans (SSASTI), Caribbeans
(CRBSTI) and nonmigrants (WSTSTI).
Let G denote the set collecting the above subgroups. Broader groups may
be defined by merging selected risk categories in G, such as migrants from
HIV-endemic areas (MGR
.
=MGRSTI∪MGRSTI) either attending (MGRSTI
.
=
SSASTI ∪CRBSTI) or not attending (MGRSTI
.
= SSASTI ∪CRBSTI) an STI
clinic; likewise, nonmigrant population clusters (WST
.
=WSTSTI∪WSTSTI)
may be similarly defined. Here it is assumed that subgroups in G are ranked
by decreasing risk of infection, so that individuals matching multiple risk
profiles are allocated into the one highest ranked: for instance, FSW who
are at the same time IDU would be classified as IDU.
Group and gender specific estimates of key parameters are derived for
three geographic regions: Amsterdam (A), Rotterdam (R) and the rest of
the country (O). Let Nr indicate the total population residing in region r,
assumed known from census statistics, and Nr,g = ρr,gNr the unknown (to
be estimated) absolute size of subgroup g ∈ G therein. Basic parameters
of interest consist of relative subgroup size ρr,g, HIV prevalence pir,g and
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proportion diagnosed with HIV δr,g for each combination of 9 subgroups g
and 3 regions r. With group-specific estimates being sought by gender (and
by STI clinic attendance status for MSM) except for the female-only FSW,
the total number of independent basic estimands thus amounts to
3× (
#{ρr,g}︷ ︸︸ ︷
9× 2− 1− 2+
#{pir,g}︷ ︸︸ ︷
9× 2− 1+
#{δr,g}︷ ︸︸ ︷
9× 2− 1) = 147,
given that regional subgroup proportions add up to 1 for each gender:∑
g ρr,g = 1 ∀r.
The HIV surveillance network in place in the Netherlands provides suffi-
cient information to infer basic parameters for most region-subgroup combi-
nations. However, data are partly lacking on proportions diagnosed (notably
among migrant subgroups) and more generally outside main urban areas.
This lack of information complicates, and in certain cases prevents, estima-
tion of relevant basic parameters, so that a direct approach in the spirit of
that outlined in Section 1 would be inapplicable. On the other hand, an
array of registry-based and ad-hoc surveys effectively targeting functional
parameters is available to supplement, from a MPES perspective, the avail-
able direct data, therefore compensating for the poor evidence on some basic
parameters. The overall data set consists of 194 items of data: 65 from Am-
sterdam, 60 from Rotterdam and 69 from the rest of the Netherlands.
Table 1 details the data collected to directly or indirectly inform HIV
epidemic descriptors in the Amsterdam area; the network of surveillance and
survey data capturing the HIV epidemic in Rotterdam and the rest of the
Netherlands is reported as Supplement A. The full array of data shows the
extent of coverage of national surveillance and highlights the links between
basic and functional parameters. Figure 1 sketches the flow of information
within the network of evidence, which is described below.
3.1. Relative subgroup sizes. Official figures from Statistics Netherlands
(CBS, source o) in Table 1 provide absolute frequencies Nr of regional
population sizes. Subgroup sizes for migrants not attending an STI clinic,
additionally obtained from CBS, are used to estimate proportions ρr,g for
g ∈MGRSTI. It should be noted, however, that CBS statistics neither track
illegal entries into the country nor distinguish between migrants attending
an STI clinic. This implies the following: (i) a downward bias undermin-
ing, to an undocumented extent, migrant-related figures; and (ii) the need
to decouple STI clinic users from nonusers. Details of how these biases are
accommodated within the MPES modeling framework are outlined in Sec-
tion 4.
Broad MSM subgroup sizes are derived from regional published popula-
tion studies (Amsterdam and Rotterdam Health Monitors, sources a and r)
and random population samples (RNG, source s; Pienter Project, source t).
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Table 1
Evidence supporting HIV prevalence estimation in Amsterdam (Nm = 284,002, Nf = 284,067); letters in brackets link to data sources as
detailed in Section 3
Basic parameters Functional parameters
Group Subgroup ρ pi δ piδ µa
MSM
STI 2,495/Nm = 0.009 (f) 606/2,723 = 0.223
b (f) 79/85 = 0.929 (g)
All 73/776 = 0.094 (a) 48/547 = 0.088 (s) 2,827c (h)
IDU
M (720–1,120)/Nm = 0.003–0.004 (i) 45/167 = 0.269
d (k) 31/45 = 0.689e (k) 37/196 = 0.189 (p) 99f (h)
F (180–280)/Nf = 6.34E–04–9.85E–04 (i) 6/30 = 0.200
d (k) 3/6 = 0.500e (k) 20/88 = 0.227 (p) 64f (h)
FSW F 7,440/Nf = 0.026 (q) 3/148 = 0.020 (q) 0/3 = 0 (q)
WSTSTI
M 5,702/Nm = 0.020 (f) 10/5,526 = 0.002
b (f) 10/(Ng,mpig,m) (f)
F 6,586/Nf = 0.023 (f) 7/6,402 = 0.001
b (f) 7/(Ng,fpig,f ) (f)
SSASTI
M 261/Nm = 0.001 (f) 7/237 = 0.030
b (f) 7/(Ng,mpig,m) (f)
F 158/Nf = 0.001 (f) 10/151 = 0.066
b (f) 10/(Ng,mpig,f ) (f)
CRBSTI
M 899/Nm = 0.003 (f) 4/855 = 0.005
b (f) 4/(Ng,mpig,m) (f)
F 771/Nf = 0.003 (f) 6/753 = 0.008
b (f) 6/(Ng,fpig,f ) (f)
SSASTI
M 9,434/Nm = 0.033
g (o) 1/129 = 0.008 (l) 173h (h)
F 8,233/Nf = 0.029
g (o) 0/50 = 0 (l) 252h (h)
CRBSTI
M 31,200/Nm = 0.110
g (o) 1/215 = 0.005 (l) 137h (h)
F 36,468/Nf = 0.128
g (o) 1/252 = 0.004 (l) 111h (h)
STI
M 8/2,135 = 0.004 (g) 2/8 = 0.250e (g)
F 7/2,580 = 0.003 (g) 3/7 = 0.429e (g)
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Table 1
(Continued)
Basic parameters Functional parameters
Group Subgroup ρ pi δ piδ µa
Mixed
M 145i (h)
F 207i (h)
Pregnant Nonmigrant 4/13,097 = 1E–04 (m) 3/4 = 0.750 (m)
women Migrant 27/3,413 = 0.008 (m) 21/27 = 0.778 (m)
aTotal Amsterdam residents for each gender are estimated (source: CBS) at 3,522 (M) and 660 (F), also including 141 and 26 cases of
unknown exposure respectively (source: SHM).
bData inform minimum prevalences, due to 278/2,495 = 0.111 (STI MSM), 182/5,702 = 0.032 (M WST), 186/6,586 = 0.028 (F WST),
26/261 = 0.100 (M SSA), 9/158 = 0.057 (F SSA), 45/899 = 0.050 (M CRB) and 19/771 = 0.025 (F CRB) STI users opt-out fractions.
cRegistered cases are underestimated by a 91/98 = 0.929 fraction (source: Schorer Monitor).
dData inform maximum prevalence.
eData inform minimum proportions diagnosed.
fRegistered cases are underestimated by uninformed gender-specific fractions.
gCounts also include STI clinic users, but exclude illegal immigrants.
hRecorded infections include both STI clinic attending and nonattending immigrants.
iMixture of respectively male and female registered infections for IDU, FSW (F only), nonmigrant STI clinic users and other.
MPES MODELING OF HIV PREVALENCE IN THE NETHERLANDS 9
Fig. 1. Schematic representation of the evidence network informing epidemiological pa-
rameters in the MPES HIV model: different samples (squares) provide data-based infor-
mation (solid arrows) around key basic (circles) and functional (ellipses) estimands, where
the latter are functionally related (dashed arrows) to the former (i.e., ρr,g, pir,g and δr,g).
These data, however, enable unbiased estimation only of ρA,MSM, as they
either under- or over-report absolute (and hence relative) sizes of MSM
subgroups living outside Amsterdam. These data are then used to inform
minimum and maximum values of the underlying subgroup sizes. The mu-
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nicipal registry of opiate and methadone users (source i) presents the same
problem when used to inform IDU prevalence in Amsterdam; the size of
the IDU population elsewhere is estimated unbiasedly through the Pienter
study and a municipal report on addiction and homelessness in Rotterdam
(source t).
Direct estimates of subgroup sizes from all STI clinic attending-subgroups
are obtained from the national registry of STI clinic consultations (SOAP,
source f). Finally, unlinked anonymous (UA) HIV surveys (source q), report-
ing results from HIV antibody testing of saliva samples from FSW in Ams-
terdam and Rotterdam, are available to directly inform ρr,FSW for r=A,R.
A published study on FSW in The Hague (source u) is utilized to inform
a range for the frequency of FSW in the rest of the country.
3.2. HIV prevalences. Evidence around HIV prevalence is more frag-
mented than that on subgroup sizes. Information relating to MSM individ-
uals is sparse, with the only direct source of evidence on piA,MSM consisting
of the Amsterdam Cohort Study (source s). Information outside urban con-
centrations is indirectly derived through data on diagnosed prevalence (i.e.,
piO,MSMδO,MSM) from the Schorer Monitor (source e), that is, the national
institute responsible for the coordination of primary HIV/STI prevention
policies targeting MSM in the Netherlands, and the Pienter Project. Since
these sources are biased downward and upward, respectively, they provide
upper and lower limits for the product piO,MSMδO,MSM. Moreover, the Pienter
data set also supplies information on diagnosed low-risk prevalence outside
main urban areas (piO,WSTSTIδO,WSTSTI).
Separate UA surveys carried out across the country allow direct estima-
tion of HIV prevalences among IDU (source k), FSW (sources k and q) and
non-STI clinic attending migrant subgroups (source l). As particularly the
UA survey covering the CRBSTI population is suspected to suffer from un-
derreporting bias, this is specifically utilized to inform a lower bound for the
corresponding prevalence parameter.
SOAP records are likely to underestimate HIV prevalence, due to an opt-
out policy in place on HIV testing in STI clinics across the Netherlands.
Information on HIV prevalence in STI clinic users is limited to those indi-
viduals actually submitting to HIV testing, while only information on atten-
dance is retained from the remaining patients. Since reluctance to submit to
HIV testing is indicative of a higher risk of HIV infection [Van der Bij et al.
(2008)], it is reasonably assumed that STI clinic users opting out of HIV
testing are more likely to be HIV positive. Details on how opt-in and opt-
out contributions to HIV prevalence parameters are decoupled and modeled
are given in Section 4.1.1. UA surveys in Amsterdam (DWAR; source g)
and Rotterdam (ROTan; source v) are also included into the network of evi-
dence, as they inform HIV prevalence among all STI clinic users (regardless
of ethnicity) in urban areas.
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Last, very little information exists on HIV prevalence affecting low-risk
subgroups. Two indirect anonymized sources can be identified: the national
antenatal screening program (source m), which monitors seroprevalence in
pregnant women across the Netherlands in 2007; and the national registry of
blood donors (Sanquin Foundation, source w), which keeps records of HIV
infections among new and regular donors in the Netherlands in 2007.
Data on blood donors are unlikely to provide unbiased evidence on HIV
prevalence in the low-risk group, as blood donors are at especially low risk of
contracting HIV. Moreover, information from Sanquin is not categorized by
either gender or region, so it captures HIV prevalence at a very coarse sub-
group level. Equally problematic, data from the national antenatal screening
program, which are broadly classified by ethnicity, provide evidence on HIV
prevalence on a population subgroup not explicitly contemplated by the
model, but rather resulting from a mixture of female subgroups in G. An
assumption of equal representativeness, in terms of risk group composition,
of pregnant women with respect to the wider female population is intro-
duced to allow modeling of this indirect (“mixed”) evidence [Presanis et al.
(2008)].
3.3. Proportions diagnosed with HIV. Many data sources already in-
forming HIV prevalence also provide evidence on the extent of disease diag-
nosis within the target subgroups. This information, however, is markedly
sparse: sample sizes are small and coverage does not extend to all region-
subgroup combinations, notably excluding MSM, MGRSTI and WSTSTI.
Biases also undermine parts of the evidence base. For instance, UA evi-
dence is known to underestimate δr,IDU, due to the especially hard-to-reach
nature of this subgroup. Data are therefore assumed to inform a lower bound
for corresponding proportions. Similarly, DWAR records on all HIV infec-
tions diagnosed in STI clinics in Amsterdam, due to intrinsic design limita-
tions, provide a downward-biased estimate of δA,STI.
3.4. Diagnosed HIV infections. The HIV Monitoring Foundation (SHM;
source h) compiles and maintains a registry of (almost2) all diagnosed HIV
cases in specialized care in the Netherlands, classified by socio-demographic
factors. Absolute counts from the relevant registry inform the regional risk
group composition of (mixtures of) prevalent HIV diagnoses: namely,
µr,g =Nrρr,gpir,gδr,g,(2)
which form a set of functional parameters (see Figure 1) involving all basic
parameters of interest. The risk subgroup classification adopted by SHM
does not coincide with that in the MPES model, since it includes mixed
2In reality, not every diagnosed HIV case makes timely (if any) contact with national
treatment facilities.
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pregnant women, SSA, CRB, WST and unclassified individuals (none in G)
as well as MSM and IDU. Additionally, cross-matching with records from
the Schorer Monitor reveals an underreporting bias affecting SHM records
on prevalent MSM cases diagnosed across the country. Finally, SHM is also
known to underreporting IDU cases in Amsterdam.
4. The MPES model structure. The above array of data on HIV preva-
lence in the Netherlands is synthesized in a Bayesian statistical model relying
upon suitably chosen standard distributions, in the spirit of case studies al-
ready documented in the literature [e.g., Ades and Sutton (2006); Goubar
et al. (2008); Presanis et al. (2008)].
4.1. Sampling distributions. Count data xr,g from a census- or survey-
type study of fixed size nr,g on subgroup g ∈ G in region r (like, e.g., SOAP
records on HIV diagnoses in STI clinics across the Netherlands) and char-
acterized by a generic probability parameter λr,g are naturally modeled via
Binomial likelihoods
xr,g|λr,g ∼Bin(nr,g, λr,g).
The total number of diagnosed HIV cases mr· on SHM record as in care
in region r is assumed to follow a Poisson distribution with regional rate
µr· =
∑
g µr,g, with µr,g defined as in (2). At the same time, the subgroup
sizes mr,g within each region are assigned a Multinomial distribution with
size parameter mr· and probability vector ξr = (ξr,g;g ∈ G) with ξr,g =
µr,g
µr·
,
so that
mr·|µr· ∼ Poi(µr·),
mr,g|mr·,ξr ∼Multin(mr·,ξr).
In practice, as explained in Section 2, interest does not always lie in the
(often functional) λ or ξ parameters, but rather in the basic parameters they
subsume in their definition. The relationship between basic and functional
parameters is formally determined by the type of mixed, biased or other-
wise indirect evidence available. Examples are illustrated in the following
sections.
4.1.1. Mixed subgroup modeling. By classifying individuals into risk
groups other than those being modeled, registry-type records provide in-
formation on proportions of diagnosed cases in each risk category (i.e., ra-
tios of the form µr,g/
∑
µr,g, rather than δr,g), possibly on suitably defined
mixtures of subgroups in G.
This is, for instance, the case with SHM which, as outlined in Section 3.4,
poses a number of modeling challenges. Unclassified individuals within its
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records are distributed proportionately across modeled risk groups, in line
with Presanis et al. (2008). Additionally, records on mixed migrant sub-
groups are modeled by STI clinic attendance status via the likelihood term
mr,g|mr·, ξr,g ∼ Bin(mr·, ξr,g)
for g ∈ {SSA,CRB}, where
ξr,SSA =
µr,SSASTI + µr,SSASTI
µr·
and
ξr,CRB =
µr,CRBSTI + µr,CRBSTI
µr·
,
where ξr,g denotes the fraction of reported regional HIV diagnoses in the
SSA= SSASTI ∪ SSASTI and CRB=CRBSTI ∪CRBSTI subgroups.
As explained in Section 3.2, estimation of the HIV prevalence pioutr,g un-
observed in subgroups opting out of HIV testing requires some modeling
assumption. Here it is assumed that prevalence among STI clinic users de-
clining an HIV test would be at least that of patients with the same risk
profile but not submitting to the test [Van der Bij et al. (2008)]. This is
formalized for g ∈ {SSASTI,CRBSTI,WSTSTI} through the decomposition
pir,g =
#infections
Nrρr,g
=
#opt-in infections
Nrρr,g
+
#opt-out infections
Nrρr,g
= piinr,g + pi
out
r,g ,
where the HIV prevalence piinr,g among those submitting to the diagnostic
test is the parameter actually being captured by regional SOAP statistics.
In Section 3.2 it was also mentioned that, in addition to SOAP, DWAR
and ROTan provide independent information on HIV prevalence and pro-
portions diagnosed among STI clinic users of ethnicity in Amsterdam and
Rotterdam, respectively. These aggregate-level data are retained into the
model to estimate corresponding parameters for r ∈ {A,R}, that is,
p˜ir,STI =
∑
g∈STI ρr,gpir,g∑
g∈STI ρr,g
,
δ˜r,STI =
∑
g∈STI ρr,gpir,gδr,g∑
g∈STI ρr,gpir,g
.
Data on low-risk women from the national antenatal screening program
are dealt with similarly.
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4.1.2. Bias modeling. In general, any sample estimating some basic pa-
rameter ϑ with bias ∆ 6= 0 can be regarded as providing indirect evidence, on
some suitable scale, on ϑ through the functional parameter ψ(ϑ) = ϑ+∆.
An example of biased evidence from the case study at hand is offered by
CBS immigration records which, as explained in Section 3.1, do not include
illegal entries and are not classified by STI clinic attendance status. Let-
ting γr,g indicate the proportion of legal migrants in region r with ethnicity
g ∈ {SSA,CRB}, CBS provides unbiased information on the relative size ρ˜r,g
of immigrant subpopulations legally living in the Netherlands: in functional
terms,
ρ˜r,SSA = γr,SSA(ρr,SSASTI + ρr,SSASTI)
and
ρ˜r,CRB = γr,CRB(ρr,CRBSTI + ρr,CRBSTI).
Since no auxiliary data are available to inform the number of illegal im-
migrants, either overall or by ethnicity, it is assumed that the proportions
1− γr,g of SSA-born (CRB-born) illegal migrants in each region ranged be-
tween 10% and 20%3 (0% and 5%) across the country [van Veen (2009)].
Furthermore, downward-biased SHM records on MSM and IDU (see Sec-
tion 3.4) are modeled by dividing parameters µr,MSM and µA,IDU with under-
reporting proportions, in turn separately estimated from the Schorer Moni-
tor and Amsterdam Cohort Study, respectively.
4.2. Prior distributions. Within a Bayesian framework, parameters of
a statistical model are given some prior probability distribution reflecting
the imperfect knowledge around them. In the present work basic parameters
are typically assigned vague prior distributions. At times, lack of informa-
tion around a significant number of parameters required introducing more
structured priors to express either known constraints or expert opinion.
4.2.1. Parameter constraints. A relatively simple example of the need
for a constraining prior distribution was offered by data from the Sanquin
Foundation. As pointed out in Section 3.2, HIV prevalence among blood
donors is expected to be significantly lower than among the wider WSTSTI
subgroup. This is accommodated within the model by assuming that infor-
mation from blood donors provides a lower bound piLWSTSTI
for WSTSTI HIV
prevalence at a national level, where
piLWSTSTI ≤ pir,WSTSTI ∀r.
3Unlike immigrants from Sub-Saharan African countries, most individuals from the
Caribbean are actually entitled lawful entry into the Netherlands.
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These assumptions are introduced to model any sample that is only known
to be biased, but without any additional information as to the extent of the
bias. These data points are annotated in detail in Table 1. In all cases the
modeling structure is naturally completed by Uniform priors defined over ap-
propriate bounds, as was done in Section 4.1.1 with the parameters pioutr,g . It
is then assumed that pir,WSTSTI ≤ming∈G pir,g, implying that WSTSTI preva-
lences should not exceed that exhibited by any other subgroup in the same
region. Last, diagnosed HIV prevalences in any STI clinic-attending sub-
group are conservatively assumed to be at least 20%, to prevent unrealisti-
cally low parameter estimates.
4.2.2. Expert opinion. Sometimes subjective prior distributions were eli-
cited from collaborating epidemiologists. This was the case with parameters
characterizing low-risk individuals and, more broadly, outside Amsterdam
and Rotterdam (see Section 3.2). Similarly to Goubar et al. (2008) and
Presanis et al. (2008), let pisr,g denote HIV prevalence among male and female
(s=m, f) individuals with risk profile g 6=MSM,FSW in region r; the male-
to-female prevalence log-odds ratio is then defined as
ηr,g = logitpi
m
r,g − logitpi
f
r,g.
A two-stage hierarchical model is formulated for prevalence log-odds ra-
tios: in the first level these are pooled across subgroups to produce shrunk
estimates η¯r; the second then pools regional log-odds ratios η¯r across the
Netherlands to derive an overall estimate η¯. The complete model specifica-
tion is thus given by
ηr,g|η¯r, σr ∼N (η¯r, σ
2
r),
(3)
η¯r|η¯, τ, σr ∼N (η¯, τ
2).
Vague hyperpriors on the national log-odds ratio (η¯) and on the re-
gional (σr) as well as national (τ ) standard deviations, respectively, measur-
ing the degree of between-subgroup and between-region heterogeneity among
prevalence log-odds ratios, complete the hierarchical model structure.
While absolute HIV prevalences should not be reasonably expected to be
distributed homogeneously across subgroups within each region, correspond-
ing male-to-female log-odds ratios can instead be more plausibly thought of
as arising from a common region-specific distribution, as implied by (3).
Shrinkage toward a regional mean allows information available around some
subgroups to supplement that around others poorly informed; see, for exam-
ple, Gelman and Hill (2007) and annotated bibliography for a comprehensive
review of the concept of “borrowing strength.”
Finally, expert opinion helps: to categorize individuals from HIV-endemic
countries by legal entry status when modeling respective subgroup sizes (as
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described in Section 4.1.2); and to infer HIV prevalences pioutr,g among STI
clinic-attending subgroups declining HIV testing (as seen in Section 4.1.1).
Additional assumptions relating to migrants and STI clinic users are mo-
tivated by the expectation of a higher proportion of HIV diagnoses among
STI clinic users, relative to nonusers with the same ethnicity and sexual
orientation. In more formal terms,
δr,SSASTI ≥ δr,SSASTI ,
δr,CRBSTI ≥ δr,CRBSTI
and
δr,MSMSTI ≥ δr,MSMSTI .
In a similar fashion, the MPES model also includes the constraints
δr,CRBSTI ≥ δr,SSASTI
and
δr,CRBSTI ≥ δr,SSASTI .
The above are motivated by a better integration in the Netherlands of
Caribbean migrants compared to Sub-Saharan Africans, who tend to be
less familiar with HIV treatment facilities and access routes to health-care
services [van Veen et al. (2005)].
4.3. Model appraisal. Recalling notation introduced in Section 2, the
standardized deviance of a particular model is defined as
D(y,ϑ) =−2 ln
L(ϑ;y)
L(ϑˆ;y)
,
where L(ϑˆ;y) is the likelihood of the saturated model (where the number of
parameters equals the number of observations), evaluated at the maximum-
likelihood estimate of ϑ.
The use of the posterior mean deviance
D¯(y) = E[D(y,ϑ)|y](4)
has been suggested by Spiegelhalter et al. (2002) as a measure of goodness of
fit: under standard regularity conditions, if the model is true, E[D¯(y)]≈ n,
so that, in particular, E[D¯(y)]≫ n would be suggestive of lack of model
fit. As the sampling distribution of D¯(y) is not well understood [Seaman,
De Angelis and Presanis (2011)], this idea is here used informally to iden-
tify conflicting information on specific parameters (see Section 6.1), through
the decomposition D¯(y) =
∑n
i=1 D¯(yi) of the deviance (4) into the individ-
ual contributions D¯(yi) made by each data point yi, i = 1, . . . , n. The fact
that, for a true model, E[D¯(yi)] ≈ 1, can be used to identify specific data
points responsible for a potential lack of fit and to investigate the likely
inconsistency in the information they provide.
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5. Results. The MPES model was fitted to the collection of surveillance
and survey data via McMC simulation using the WinBUGS statistical package
[Lunn et al. (2000)]. The code and data required to produce model estimates
are provided as Supplement B. The sampling algorithm was started at three
independent initial states, with convergence ascertained by both visual and
formal diagnostic means [Gelman and Rubin (1992)] after 30,000 iterations.
After thinning, a 30,000-sized sample from the full posterior distribution
was subsequently retained for drawing inferences.
5.1. Model inferences. Point and interval estimates around basic popu-
lation and HIV-related parameters are presented by risk group for the Am-
sterdam area in Table 3, together with predicted number of HIV infections
classified by diagnosis status; inferences for the remaining georgraphic areas
across the Netherlands are presented as Supplement C.
Most posterior distributions tend to concentrate around parameter val-
ues regarded as plausible by the collaborating epidemiologists, usually with
a reasonable level of accuracy, given the uncertainty affecting the underlying
data. In particular, predicted numbers of prevalent (Nrρr,gpir,g) and undi-
agnosed (Nrρr,gpir,g(1− δr,g)) cases—the key inputs to health-care decision-
making—appear in line with expectations and concur with results from al-
ternative analytical frameworks [van Veen et al. (2011)].
Estimates in general reflect the varying accuracy of regional collection
networks, as well as local patterns of subgroup composition: the precision
of inferences can be seen to broadly decrease when moving from urban con-
centrations (like Amsterdam, Table 3) into smaller subgroups/areas across
the Netherlands (see Supplement C). This is, for instance, the case with
estimated proportions of prevalent MSM cases diagnosed outside Amster-
dam and Rotterdam (δˆO,MSM, see Supplement C), which are also signifi-
cantly lower than those from the two main cities (see, e.g., δˆA,MSM from Ta-
ble 3). Due to the lack of studies targeting δO,MSM, this can only be inferred
indirectly from diagnosed HIV cases (µO,MSM) and diagnosed prevalence
(piO,MSMδO,MSM), the latter in turn being informed by two biased studies.
The uncertainty around resulting MPES estimates is just a consequence of
the synthesis between such scarce evidence and the mild ranking assump-
tions on δr,g detailed in Section 4.2.2.
Estimated proportions of prevalent IDU cases diagnosed in Amsterdam
(δA,IDU from Table 3) are higher than elsewhere in the Netherlands (δr,IDU
for r 6=A from Supplement C). Critical appraisal of δˆA,IDU is complicated by
the large number of data sources involved. Direct data-based estimates (Ta-
ble 1) can be seen to be much lower than those produced by the MPES model
(Table 3). At the same time, however, the number µA,IDU of diagnosed HIV
infections, which suffers from underreporting (see Section 3.4), disagrees
with direct information separately available on its building blocks piA,IDU
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and δA,IDU (see Section 3.3). On the other hand, evidence listed in Table 1
on piA,IDU and µA,IDU, while biased, is overall firmer than that around δA,IDU
and therefore weighs more in the synthesis process. In broad terms, records
on diagnosed infections can be seen as an “anchor” to the balance between
piA,IDU and δA,IDU: by definition, the same number of diagnosed HIV in-
fections µr,g can be obtained with different combinations of prevalent cases
Nrρr,gpir,g and fractions diagnosed δr,g. Since available information allows for
more accurate estimation of piA,IDU compared to δA,IDU, the MPES model
reconciles conflicting evidence around µA,IDU by favoring larger estimates of
the more uncertain δA,IDU over correspondingly lower values of piA,IDU.
6. Discussion. Recent applied work has consolidated the role of MPES
as a modeling framework for the estimation of epidemiological indicators of
infectious diseases [Ades (2003); Welton and Ades (2005); Ades et al. (2006,
2008); Goubar et al. (2008); Presanis et al. (2008); De Angelis et al. (2009)].
This has paved the way for governmental institutions (e.g., the Medical Re-
search Council, the National Institute for Health and Clinical Excellence and
the Health Protection Agency in the UK) and international bodies (e.g., the
World Health Organization and UNAIDS) to increasingly rely on formal ev-
idence synthesis as an analytic tool to advance epidemiological understand-
ing and support medical decision-making. The present work represents an
additional step toward expansion of the range of applicability of the MPES
approach, as it illustrates the experience of HIV prevalence estimation in the
Netherlands, a western European country with a concentrated HIV epidemic
and reasonably consolidated and accessible HIV specialist care.
While relatively extensive in terms of geographic and behavioral cover-
age, the array of surveillance and survey data made available by the Dutch
National Institute for Public Health and the Environment required a com-
prehensive reappraisal at an evidence synthesis stage. Problems in the evi-
dence body were identified through an informal use of deviance statistics in
terms of conflicting, biased or insufficient data on certain region-subgroup
combinations. Inconsistencies thus detected were mostly resolved by using
additional data and/or expert beliefs provided by collaborating epidemiolo-
gists. Nevertheless, some evidence of conflict remained, as indicated by the
overall mean posterior deviance of 258.139, compared to a total of 186 obser-
vations.4 This conflict is mainly around evidence informing HIV prevalence
among migrant women in the rest of the Netherlands, for which collection of
further information was consequently recommended. Ultimately, model esti-
mates broadly met the expectations of the pool of epidemiologists involved
in the case study.
4This differs from the nominal total of 194 (see Section 3) in that it excludes overly
sparse samples—like those from SOAP leading to 0 or 1 maximum likelihood estimates of
some δr,g parameters—not meeting the regularity conditions mentioned in Section 4.3.
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6.1. The role within MPES of direct and indirect evidence. In general,
the process of amalgamating all knowledge available is expected to produce
more accurate inferences than those resulting from a partial or no synthesis.
However, as anticipated in Section 1, the availability of multiple evidence
sources on given parameters can lead to the utilization of discrepant, if
not conflicting, items of information. These discrepancies typically originate
from an incorrect interpretation of what the data represent (e.g., unrecog-
nized biases), which consequently are inadequately modeled. If these incon-
sistencies remain unresolved, MPES inferences may be less accurate than
those obtained from using direct information alone. This is because MPES
estimates arise as a compromise between estimates separately informed by
direct and indirect evidence only, the more precise of the two weighting more
in the balance. The MPES approach allows resolution of inconsistencies by
explicitly modeling the conflicting items of evidence [e.g., by accounting for
biases in the data, as in Ades and Cliffe (2002); Presanis et al. (2008)]. In
practice, this is achieved via an interactive reappraisal process, involving the
statisticians and collaborating epidemiologists, of the data sources flagged
by the MPES model as conflicting. Ultimately, any unresolved conflict of
evidence on some parameter would be symptomatic of the need for addi-
tional information—either in the form of field data or of expert opinion—to
be collected.
As explained in Section 4.3, examination of the contribution D¯(yi) pro-
vided by each data point yi to the posterior mean deviance (4) allows identi-
fication of conflicts between direct and indirect evidence: for a given item of
direct evidence, the farther from 1 its contribution to (4), the more marked
the discrepancy of the information it provides on a particular parameter with
the remaining available evidence. This is illustrated in Table 2, which for
selected basic parameters reports the posterior mean deviance contributions
Table 2
Posterior mean deviances (computed from direct items of evidence only) and posterior
medians with 95% credibility intervals for selected basic parameters, obtained from
modeling available direct evidence only, indirect evidence only and all evidence
Inferences (%)
Parameter Deviance Direct Indirect MPES Full MPES
pimR,CRBSTI 1.664 1.194 (0.416, 2.598)
a 1.393 (1.000, 2.194) 1.492 (1.014, 2.451)
pifR,IDU 1.887 14.489 (8.389, 22.488) 7.461 (4.198, 13.250) 10.060 (6.612, 15.030)
ρA,MSM 2.102 9.372 (7.456, 11.557) 13.750 (10.240, 21.240) 10.750 (9.173, 12.560)
pifO,CRB
STI
8.463 1.515 (0.529, 3.292) 0.191 (0.164, 0.222) 0.194 (0.166, 0.226)
pimO,SSA
STI
9.346 1.116 (0.162, 3.658)a 3.838 (2.228, 6.214) 3.926 (2.227, 6.345)
aDirect evidence is known to be up- or down-ward biased.
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Table 3
Posterior medians with 95% credibility intervals of epidemiological parameters and total (Nρpi) and undiagnosed
(Nρpi(1− δ) =Nρpi− µ) infections from the MPES model of HIV prevalence in Amsterdam
Group Subgroup ρˆ (%) pi (%) δˆ (%) N̂ρpi N̂ρpi− µˆ
MSM
STI 0.879 (0.844, 0.913) 29.100 (24.910, 33.800) 93.510 (87.810, 97.210) 726 (617, 846) 46 (19, 91)
Non-STI 9.871 (8.298, 11.680) 9.641 (8.074, 11.590) 88.730 (74.900, 95.370) 2,682 (2,380, 3,208) 301 (113, 800)
All 10.750 (9.173, 12.560) 11.250 (9.645, 13.180) 89.640 (78.130, 95.570) 3,404 (3,138, 3,931) 351 (140, 854)
IDU
M 0.332 (0.256, 0.399) 21.365 (15.690, 28.100) 90.700 (69.660, 99.630) 198 (132, 286) 18 (0, 76)
F 0.093 (0.074, 0.108) 27.260 (21.180, 35.520) 93.280 (73.751, 99.700) 71 (54, 95) 4 (0, 22)
MF 0.212 (0.173, 0.248) 22.650 (17.840, 28.590) 90.790 (72.441, 99.610) 270 (198, 362) 24 (0, 90)
FSW F 2.620 (2.561, 2.679) 3.133 (1.192, 6.252) 33.975 (4.950, 69.159) 233 (88, 467) 148 (43, 367)
WSTSTI
M 2.008 (1.958, 2.061) 0.297 (0.184, 0.577) 57.630 (26.940, 91.490) 16 (10, 32) 7 (0, 23)
F 2.318 (2.265, 2.376) 0.168 (0.112, 0.317) 64.910 (32.590, 93.410) 11 (7, 20) 3 (0, 12)
MF 2.164 (2.126, 2.202) 0.234 (0.153, 0.397) 59.070 (32.140, 90.579) 28 (18, 48) 11 (1, 31)
SSASTI
M 0.091 (0.080, 0.102) 3.732 (2.686, 6.541) 79.315 (47.120, 97.290) 9 (7, 16) 1 (0, 8)
F 0.056 (0.048, 0.065) 7.348 (5.947, 9.797) 83.700 (68.730, 97.040) 11 (10, 15) 1 (0, 4)
MF 0.073 (0.067, 0.081) 5.179 (4.160, 7.164) 80.580 (59.801, 96.700) 21 (17, 29) 4 (0, 11)
CRBSTI
M 0.315 (0.295, 0.337) 0.600 (0.452, 1.119) 84.500 (54.521, 97.860) 5 (4, 10) 0 (0, 4)
F 0.271 (0.252, 0.290) 0.917 (0.767, 1.340) 87.630 (73.252, 97.890) 7 (6, 10) 0 (0, 2)
MF 0.293 (0.279, 0.307) 0.763 (0.624, 1.108) 85.360 (66.271, 97.380) 12 (10, 18) 1 (0, 5)
SSASTI
M 3.825 (3.590, 4.071) 1.899 (1.186, 3.278) 64.050 (35.030, 88.019) 206 (129, 356) 73 (17, 222)
F 3.394 (3.161, 3.587) 3.503 (2.877, 4.371) 72.300 (59.431, 83.320) 336 (279, 415) 93 (48, 164)
MF 3.607 (3.430, 3.781) 2.671 (2.142, 3.531) 68.670 (51.800, 81.030) 546 (441, 719) 170 (88, 342)
CRBSTI
M 10.970 (10.650, 11.280) 0.442 (0.292, 0.693) 75.720 (46.760, 91.440) 137 (90, 214) 32 (9, 106)
F 12.910 (12.550, 13.270) 0.375 (0.294, 0.479) 80.270 (66.860, 92.130) 137 (107, 175) 26 (9, 55)
MF 11.940 (11.680, 12.200) 0.407 (0.319, 0.539) 77.410 (59.160, 89.000) 276 (216, 365) 61 (26, 144)
WSTSTI
M 71.710 (69.840, 73.360) 0.065 (0.040, 0.129) 80.750 (39.700, 98.710) 132 (81, 264) 24 (1, 152)
F 78.350 (77.890, 78.800) 0.066 (0.033, 0.109) 85.020 (54.701, 98.800) 147 (72, 242) 21 (1, 81)
MF 75.030 (74.070, 75.880) 0.067 (0.042, 0.107) 82.180 (49.150, 98.530) 284 (180, 455) 48 (3, 216)
Total
M 100 (100, 100) 1.459 (1.335, 1.679) 86.655 (75.320, 93.860) 4,143 (3,791, 4,768) 553 (234, 1,170)
F 100 (100, 100) 0.340 (0.286, 0.422) 67.075 (53.860, 78.700) 965 (812, 1,200) 316 (174, 550)
MF 100 (100, 100) 0.901 (0.831, 1.017) 82.690 (73.560, 89.200) 5,120 (4,720, 5,777) 885 (512, 1,521)
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to (4), based on their respective direct-only evidence, alongside correspond-
ing inferences obtained from separately utilizing direct, indirect and full in-
formation. The benefit of full evidence synthesis in the presence of broadly
agreeing sources of information is made obvious by estimates of pimR,CRBSTI
and pifR,IDU: respective MPES inferences combine direct and indirect evi-
dence, whose consistency is highlighted by deviance statistics close to 1,
to produce narrower credibility intervals than those arising from a direct
approach. Moderately discrepant information is instead reconciled within
the MPES model through a compromise between direct- and indirect-only
inferences: this, as in the case of ρA,MSM, yields a credibility interval not sig-
nificantly narrower than its direct counterpart, since it conveys not only the
uncertainty within, but also the variability between, the items of evidence
it involves.
The same rationale applies to MPES inferences on parameters informed
by conflicting evidence: similarly to ρA,MSM, MPES credibility intervals
around pifO,CRBSTI
and pimO,SSASTI
offer a compromise between the direct and
indirect information separately contributing to their estimation. The syn-
thesized inferences, however, are clearly less accurate than their respective
direct versions, due to the extent of the inconsistency undermining the infor-
mation on pifO,CRBSTI
and pimO,SSASTI
, as also indicated by the correspondingly
large deviance statistics. In this case, while seemingly offering no immedi-
ate advantage over a direct method, the deviant MPES estimates point to
those parts of the evidence body which remain inconsistent, hence suggest-
ing what type of supplementary information would be most useful to resolve
the discrepancy.
Furthermore, it can be seen that the leverage each evidence source applies
to the final MPES estimate is determined by its corresponding sample size,
not by it being graded as “direct” or “indirect”: this is shown in Table 2
with pifO,CRBSTI
, whose estimate is more driven by the stronger indirect evi-
dence. Finally, it is worth noting that the availability, in a MPES setup, of
different sets of inferences, each resulting from a different level of evidence
synthesis, further stresses the robustness and efficiency of a full MPES ap-
proach over any arbitrary selection of items from the complete evidence
base. Eventually the MPES approach contributed to a better understanding
of the nature of those evidence conflicts which, pending the availability of
additional data (the provision of which will be discussed for future updates
of national estimates), remain unresolved.
6.2. Prior information in MPES. As detailed in Section 4.2, the pre-
sented MPES model relies on a number of prior assumptions. This is in
line with the MPES spirit of informing the analysis with all available evi-
dence, not just “hard” data. Often reliance on expert opinion is regarded as
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inappropriate, in that if misused it could steer the analysis toward partly
subjective outcomes. On the other hand, as notably pointed out in Robert
[(2007), Chapter 1], knowledge does not exclusively derive from field data,
but actually builds on it. Substantive prior information informing the illus-
trated case study was typically introduced pragmatically: earlier versions of
the MPES model featuring fewer/milder prior assumptions than those listed
in Section 4.2 produced overly inaccurate (i.e., with unduly wide credibility
bounds) estimates for some poorly informed subgroup-region combinations.5
An MPES model can help in identifying those parameters whose estimation
would benefit the most from the collection of larger/additional samples. To
this end, while MPES modeling falls short of indicating which design strat-
egy would yield largest efficiency gains, insights in this respect are naturally
offered by more formal decision-theoretic tools, such as those based on the
concept of value of information [Parmigiani and Inoue (2009), Chapter 13].
While these are receiving increasing attention by the environmental and
health sciences community, they remain the subject of ongoing investigation
and fall outside the remit of this paper.
6.3. Current HIV prevalence estimation platforms. The MPES approach
lends itself as a valuable framework for national HIV prevalence estimation.
Alternative options have been freely made available in recent years by the
UNAIDS Reference Group on Estimates, Modeling and Projections: that
is, the Estimation and Projection Package [EPP, Ghys et al. (2004); Brown
et al. (2006)] and the Workbook Method [Walker et al. (2004); Lyerla et al.
(2006)], each implemented in a bespoken software package (unlike MPES).
EPP assumes the national population is subdivided into nonoverlapping
risk subgroups, for which historical records of size and HIV prevalence are
available. EPP then fits a simple transmission model to the prevalence data
via Sampling Importance Resampling from a Bayesian Melding perspective
[Poole and Raftery (2000)], generating a cluster of epidemic curves for each
urban/rural and subgroup-specific sub-epidemic [Alkema, Raftery and Clark
(2007); Raftery and Bao (2010)]. Resulting national HIV prevalence and
incidence projections can then be fed into the stand-alone Spectrum module
[Stover (2004)] to predict over time the number of individuals living with
HIV or AIDS, new HIV infections, etc.
The Workbook Method estimates and projects HIV prevalence in coun-
tries lacking an HIV surveillance network consistently monitoring local preva-
lence patterns over time. Similarly to MPES and EPP, albeit to a coarser
degree, Workbook estimates rely on a classification of the target population
by risk profiles for which values of the maximum and minimum size and
5Results not shown.
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of HIV prevalence are available. The various combinations of lower-upper
bounds are then cross-multiplied and averaged to obtain informal “plausi-
bility” ranges for national HIV prevalence. This in turn can be imported
into EPP/Spectrum to obtain a wider array of ancillary HIV epidemic de-
scriptors.
A comparative discussion of the advantages and shortfalls of the three ap-
proaches (MPES, EPP/Spectrum, Workbook) is presented elsewhere [van
Veen et al. (2011)]. Extensive criticism of Workbook estimates has led to
a marked shift toward utilization and development of EPP among epidemi-
ologists and practitioners in the field. While MPES has been only recently
extended to HIV prevalence estimation, its flexibility shows promise for ap-
plication to increasingly varied and complex data structures. Successful im-
plementations have been carried out to incorporate time-series data for the
estimation of HIV prevalence and incidence trends and patterns among MSM
in England and Wales [Presanis et al. (2011)]. Additional case studies to be
conducted via MPES modeling are currently being sought among eastern
European countries, since this should facilitate the continuing development
necessary for the methodology to reach higher levels of dissemination and
maturity.
Acknowledgments. The authors gratefully acknowledge all institutions,
data managers and researchers who supplied data as well as valuable dis-
cussion and follow-up. The authors are also grateful to three anonymous
referees for their helpful advice and comments.
SUPPLEMENTARY MATERIAL
Supplement A: HIV prevalence data in Rotterdam and the rest of the
Netherlands (DOI: 10.1214/11-AOAS488SUPPA; .ps). Surveillance- and sur-
vey-type data supporting HIV prevalence estimation Rotterdam and the
Rest of the Netherlands.
Supplement B: MPES model and data files
(DOI: 10.1214/11-AOAS488SUPPB; .zip). WinBUGS code of the MPES model
and data inputs enabling HIV prevalence estimation in the Netherlands.
Supplement C: HIV prevalence estimates in Rotterdam and the Nether-
lands (including and excluding Amsterdam)
(DOI: 10.1214/11-AOAS488SUPPC; .ps). Posterior inferences on HIV preva-
lence descriptors by risk subgroup in Rotterdam and the Netherlands (sep-
arately including and excluding Amsterdam and Rotterdam).
REFERENCES
Ades, A. E. (2003). A chain of evidence with mixed comparisons: Models for multi-
parameter synthesis and consistency of evidence. Stat. Med. 22 2995–3016.
24 S. CONTI ET AL.
Ades, A. E. and Cliffe, S. (2002). Markov Chain Monte Carlo estimation of a mul-
tiparameter decision model: Consistency of evidence and the accurate assessment of
uncertainty. Medical Decision Making 22 359–371.
Ades, A. E. and Sutton, A. J. (2006). Multiparameter evidence synthesis in epidemi-
ology and medical decision-making: Current approaches. J. R. Stat. Soc. Ser. A Stat.
Soc. 169 5–35. MR2222010
Ades, A. E., Sculpher, M., Sutton, A., Abrams, K., Cooper, N., Welton, N. and
Lu, G. (2006). Bayesian methods for evidence synthesis in cost-effectiveness analysis.
Pharmacoeconomics 24 1–19.
Ades, A. E.,Welton, N. J., Caldwell, D., Price, M.,Goubar, A. and Lu, G. (2008).
Multiparameter evidence synthesis in epidemiology and medical decision-making. Jour-
nal of Health Services Research & Policy 13 12–22.
Alkema, L., Raftery, A. E. and Clark, S. J. (2007). Probabilistic projections of HIV
prevalence using Bayesian melding. Ann. Appl. Stat. 1 229–248. MR2393849
Benson, K. and Hartz, A. (2000). A comparison of observational studies and randomized
controlled trials. New England Journal of Medicine 342 1878–1886.
Berkey, C. S., Hoaglin, D. C., Antczak-Bouckoms, A., Mosteller, F. and
Colditz, G. A. (1998). Meta-analysis of multiple outcomes by regression with ran-
dom effects. Stat. Med. 17 2537–2550.
Brookmeyer, R. andGail, M. H. (1988). A method for obtaining short-term projections
and lower bounds on the size of the AIDS epidemic. J. Amer. Statist. Assoc. 83 301–308.
Brown, T., Grassly, N. C., Garnett, G. and Stanecki, K. (2006). Improving pro-
jections at the country level: The UNAIDS estimation and projection package 2005.
Sexually Transmitted Infections 82 iii34–iii40.
Burzykowski, T.,Molenberghs, G. and Buyse, M. (2004). The validation of surrogate
end points by using data from randomized clinical trials: A case-study in advanced
colorectal cancer. J. Roy. Statist. Soc. Ser. A 167 103–124. MR2043435
Caldwell, D. M., Ades, A. E. and Higgins, J. P. T. (2005). Simultaneous comparison
of multiple treatments: Combining direct and indirect evidence. British Medical Journal
331 897–900.
Claxton, K. P., Sculpher, M. J. and Drummond, M. (2002). A rational framework
for decision making by the national institute for clinical excellence (NICE). The Lancet
360 711–715.
De Angelis, D., Sweeting, M.,Ades, A. E., Hickman, M.,Hope, V. and Ramsay, M.
(2009). An evidence synthesis approach to estimating hepatitis C prevalence in England
and Wales. Stat. Methods Med. Res. 18 361–379. MR2750101
Dominici, F., Parmigiani, G., Wolpert, R. L. and Hasselblad, V. (1999). Meta-
analysis of migraine headache treatments: Combining information from heterogeneous
designs. J. Amer. Statist. Assoc. 94 16–28.
Drioycour, F., Silberman, G. and Chelimsky, E. (1993). Cross-design synthesis:
A new form of meta-analysis for combining the results from randomised clinical tri-
als and medical-practice databases. International Journal of Technology Assessment in
Health Care 9 440–449.
Eddy, D. M. and Hasselblad, V. (1992). Meta-analysis by the Confidence Profile
Method. Academic Press, Boston, MA.
Fuentes, M. and Raftery, A. E. (2005). Model evaluation and spatial interpolation by
Bayesian combination of observations with outputs from numerical models. Biometrics
61 36–45. MR2129199
MPES MODELING OF HIV PREVALENCE IN THE NETHERLANDS 25
Gelman, A. and Hill, J. (2007). Data Analysis Using Regression and Multilevel/
Hierarchical Models. Analytical Methods for Social Research. Cambridge Univ. Press,
Cambridge.
Gelman, A. and Rubin, D. B. (1992). Inference from iterative simulation using multiple
sequences. Statist. Sci. 7 457–472.
Ghys, P. D., Brown, T., Grassly, N. C., Garnett, G., Stanecki, K. A., Stover, J.
andWalker, N. (2004). The UNAIDS Estimation and Projection Package: A Software
Package to Estimate and Project National HIV Epidemics. British Medical Journal 80
i5–i9.
Giesecke, J., Johnson, A., Hawkins, A., Noone, A. and Nicoll, A. (1994). An es-
timate of the prevalence of human immunodeficiency virus infection in England and
Wales by using a direct method. J. Roy. Statist. Soc. Ser. A 157 89–103.
Goubar, A., Ades, A. E., De Angelis, D., McGarrigle, C. A., Mercer, C. H.,
Tookey, P. A., Fenton, K. and Gill, O. N. (2008). Estimates of human immunode-
ficiency virus prevalence and proportion diagnosed based on Bayesian multi-parameter
synthesis of surveillance data. J. Roy. Statist. Soc. Ser. A 171 541–580. MR2432503
HIV & STI Department (2005). Mapping the issues. HIV and other sexually transmitted
infections in the United Kingdom 2005. Technical report, Health Protection Agency.
HIV & STI Department (2006). A complex picture. HIV and other sexually transmitted
infections in the United Kingdom 2006. Technical report, Health Protection Agency.
HIV & STI Department (2007). Testing times. HIV and other sexually transmitted
infections in the United Kingdom 2007. Technical report, Health Protection Agency.
HIV & STI Department (2008). HIV in the United Kingdom: 2008 report. Technical
report, Health Protection Agency.
HIV & STI Department (2009). HIV in the United Kingdom: 2009 report. Technical
report, Health Protection Agency.
Houweling, H., Heisterkamp, S. H., Wiessing, L. G., Coutinho, R. A., van Wijn-
gaarden, J. K. and Jager, H. J. C. (1998). Methods for estimating HIV prevalence:
A comparison of extrapolation from surveys on infection rate and risk behaviour with
back-calculation for the Netherlands. European Journal of Epidemiology 14 645–652.
Karon, J. M., Khare, M. and Rosenberg, P. S. (1998). The current status of methods
for estimating the prevalence of human immunodeficiency virus in the United States of
America. Stat. Med. 17 127–142.
Lu, G. and Ades, A. E. (2004). Combination of direct and indirect evidence in mixed
treatment comparisons. Stat. Med. 23 3105–3124.
Lunn, D. J., Thomas, A., Best, N. and Spiegelhalter, D. (2000). WinBUGS—
A Bayesian modelling framework: Concepts, structure, and extensibility. Stat. Comput.
10 325–337.
Lyerla, R., Gouws, E., Garcia-Calleja, J. M. and Zaniewski, E. (2006). The 2005
workbook: An improved tool for estimating HIV prevalence in countries with low level
and concentrated epidemics. Sexually Transmitted Infections 82 iii41–iii44.
McGarrigle, C. A., Cliffe, S., Copas, A. J., Mercer, C. H., De Angelis, D.,
Fenton, K. A., Evans, B. G., Johnson, A. M. and Gill, O. N. (2006). Estimating
adult HIV prevalence in the UK in 2003: The direct method of estimation. British
Medical Journal 82 78–86.
Nam, I. S., Mengersen, K. and Garthwaite, P. (2003). Multivariate meta-analysis.
Stat. Med. 22 2309–2333.
Parmigiani, G. and Inoue, L. (2009). Decision Theory: Principles and Approaches. Wi-
ley, Chichester. MR2604978
26 S. CONTI ET AL.
Petruckevitch, A., Nicoll, A., Johnson, A. and Bennett, D. (1997). Direct esti-
mates of prevalent HIV infection in adults in England and Wales for 1991 and 1993:
An improved method. Genitourinary Medicine 73 348–354.
Poole, D. and Raftery, A. E. (2000). Inference for deterministic simulation models:
The Bayesian melding approach. J. Amer. Statist. Assoc. 95 1244–1255. MR1804247
Presanis, A. M., De Angelis, D., Spiegelhalter, D. J., Seaman, S., Goubar, A.
and Ades, A. E. (2008). Conflicting evidence in a Bayesian synthesis of surveillance
data to estimate HIV prevalence. J. Roy. Statist. Soc. Ser. A 171 915–937. MR2530293
Presanis, A. M., De Angelis, D., Goubar, A., Gill, O. N. and Ades, A. E. (2011).
Bayesian evidence synthesis for a transmission dynamic model for HIV among men who
have sex with men. Biostatistics 0 1–16.
Raftery, A. E. and Bao, L. (2010). Estimating and projecting trends in HIV/AIDS
generalized epidemics using incremental mixture importance sampling. Biometrics.
Ramo´n, J. S., Alvarenga, M.,Walker, N.,Garcia-Calleja, J. M. and Zacarias, F.
(2002). Estimating HIV/AIDS prevalence in countries with low-level and concentrated
epidemics: The example of Honduras. AIDS 16 S18–S22.
Robert, C. P. (2007). The Bayesian Choice: From Decision-Theoretic Foundations to
Computational Implementation, 2nd ed. Springer, New York. MR2723361
Seaman, S.,De Angelis, D. and Presanis, A. M. (2011). Using posterior mean deviance
to assess Bayesian model fit. Personal communication.
Song, F., Altman, D. G., Glenny, A. M. and Deeks, J. J. (2003). Validity of indirect
comparison for estimating efficacy of competing interventions: Empirical evidence from
published meta-analyses. British Medical Journal 326 472–476.
Spiegelhalter, D. J. and Best, N. G. (2003). Bayesian approaches to multiple sources
of evidence and uncertainty in complex cost-effectiveness modelling. Stat. Med. 22 3687–
3709.
Spiegelhalter, D. J., Best, N. G., Carlin, B. P. and van der Linde, A. (2002).
Bayesian measures of model complexity and fit. J. R. Stat. Soc. Ser. B Stat. Methodol.
64 583–639. MR1979380
Stover, J. (2004). Projecting the demographic consequences of adult HIV prevalence
trends: The spectrum projection package. Sexually Transmitted Infections 80 i14–i18.
Sutton, A. J., Abrams, K. R., Jones, D. R., Sheldon, T. A. and Song, F. (2000).
Methods for Meta-Analysis in Medical Research. Wiley, Chichester.
Sweeting, M. J., De Angelis, D., Hickman, M. and Ades, A. E. (2008). Estimating
hepatitis C prevalence in england and Wales by synthesizing evidence from multiple
data sources. Assessing data conflict and model fit. Biostatistics 9 715–734.
Turner, R. M., Spiegelhalter, D. J., Smith, G. C. S. and Thompson, S. G. (2009).
Bias modelling in evidence synthesis. J. Roy. Statist. Soc. Ser. A 172 21–47. MR2655603
Van der Bij, A. K., Dukers, N. H. T. M., Coutinho, R. A. and Fennema, H. S. A.
(2008). Low HIV-testing rates and awareness of HIV infection among high-risk hetero-
sexual STI clinic attendees in The Netherlands. The European Journal of Public Health
18 376–379.
van Veen, M. G. (2009). Interim meeting. Personal communication.
van Veen, M. G., Wagemans, M. A. J., Op de Coul, E. L. M., Fennema, J. S. A.,
van der Helm, T. C. M., Walter, J., Prins, M. and van der Laar, M. J. W.
(2005). HIV-surveys among high risk populations in Amsterdam 2003–2004. Technical
report, National Institute for Public Health and the Environment, Bilthoven, Nether-
lands. (In Dutch.)
van Veen, M. G., Presanis, A. M., Conti, S., Xiridou, M., Rinder Stengaard, A.,
Donoghoe, M. C., van Sighem, A., van der Sande, M. and De Angelis, D. (2011).
MPES MODELING OF HIV PREVALENCE IN THE NETHERLANDS 27
National estimate of HIV prevalence in The Netherlands: Comparison and applicability
of different estimation tools. AIDS 25 229–237.
Walker, N., Stover, J., Stanecki, K., Zaniewski, A. E., Grassly, N. C., Garcia-
Calleja, J. M. and Ghys, P. D. (2004). The workbook approach to making estimates
and projecting future scenarios of HIV/AIDS in countries with low level and concen-
trated epidemics. Sexually Transmitted Infections 80 i10–i13.
Welton, N. J. and Ades, A. E. (2005). A model of toxoplasmosis incidence in the UK:
Evidence synthesis and consistency of evidence. J. Roy. Statist. Soc. Ser. C 54 385–404.
MR2135881
Whitehead, A. (2002). Meta-Analysis of Controlled Clinical Trials. Wiley, Chichester.
Wolpert, R. L. andMengersen, K. L. (2004). Adjusted likelihoods for synthesizing em-
pirical evidence from studies that differ in quality and design: Effects of environmental
tobacco smoke. Statist. Sci. 19 450–471. MR2185626
S. Conti
Statistics Unit
Centre for Infections
Health Protection Agency
61 Colindale Avenue
London NW9 5EQ
United Kingdom
E-mail: stefano.conti@hpa.org.uk
A. M. Presanis
MRC Biostatistics Unit
Institute of Public Health
University Forvie Site
Robinson Way
Cambridge CB2 0SR
United Kingdom
M. G. van Veen
M. Xiridou
National Institute for Public Health
and the Environment
PO Box 1
3720 BA Bilthoven
The Netherlands
M. C. Donoghoe
A. Rinder Stengaard
World Health Organization
Regional Office for Europe
Scherfigsvej 8
DK-2100 Copenhagen Ø
Denmark
D. De Angelis
Statistics Unit
Centre for Infections
Health Protection Agency
61 Colindale Avenue
London NW9 5EQ
United Kingdom
and
MRC Biostatistics Unit
Institute of Public Health
University Forvie Site
Robinson Way
Cambridge CB2 0SR
United Kingdom
